This websites contains videos from YouTube. This company uses
cookies (third party cookies). If you do not want them to use these
cookies, you can indicate so here. However, this does mean that you
will not be able to watch videos on this website. We also make use
of our own cookies in order to improve our website. We don't share
our data with other parties. Which cookies are involved?
user experience. If you do not want to accept these cookies,
indicate so here. Which cookies are involved?
Dutch Cancer Society: nearly €17 million a year for the Netherlands Cancer Institute
Far-reaching cooperation to benefit cancer
Today the Dutch Cancer Society and the Netherlands Cancer
Institute signed a new cooperation agreement covering the next five
years. It devotes an annual €16.8 million to advanced quality
cancer research at the Netherlands Cancer Institute.
Fred Falkenburg, director of the Dutch Cancer Society: "Over the
years the Netherlands Cancer Institute has grown into a first-rate
oncological institute, both nationally and internationally, thanks
to its powerful combination of excellent research, high-quality
patient care, and the ability to put scientific research into
practice. This is in the interests of cancer patients, and thanks
to the generosity of our donors we can give it substantial
René Medema, Chairman and Scientific Director of the Netherlands
Cancer Institute, is extremely pleased with the renewed agreement:
"The link between the Dutch Cancer Society and the Netherlands
Cancer Institute is a strong one and goes back to 1951. Over the
years we have succeeded in understanding and treating cancer better
and better. The fact that the Dutch Cancer Society is supporting us
with this funding attests to their strong confidence in our
In the years to come the Dutch Cancer Society and the Netherlands
Cancer Institute will be collaborating on the basis of three
The results of scientific research must be made accessible to
patients more quickly. The targeted follow-up development of
laboratory research towards its practical use should lead to the
earliest possible application of research results in patients.
Both new and existing drug treatments should be made more
readily available. The Dutch Cancer Society and the Netherlands
Cancer Institute are developing new models for the production and
registration of cancer medicines, and are working together to
influence government policy in order to break the barriers that
impede patient access to new medicines and treatment methods.
Improving the quality of life of everyone facing cancer or
dealing with its aftermath. 'Quality of life' is one of the
Netherlands Cancer Institute's five focus areas. By doing
innovative research into the psychosocial effects and after-effects
of the disease, and by implementing the results of this research in
patient care, the Netherlands Cancer Institute can make a
significant contribution towards improving patients' quality of
life during, and after, cancer.